LA Mayor Signs Order to Restrict Flavored Tobacco Sales

Aug.25.2022
LA Mayor Signs Order to Restrict Flavored Tobacco Sales
Los Angeles bans flavored tobacco sales, effective January 2023, citing harm to public health and disproportionately affecting minority groups.

On June 13th, Los Angeles Mayor Eric Garcetti signed an ordinance to restrict the sale of menthol cigarettes and other flavored tobacco products. The ordinance will take effect on January 1, 2023. As of June 16th, 2022, the Smoke-Free Kids campaign reported that 127 local governments in California have passed restrictions on the sale of flavored tobacco products. At least 108 of those jurisdictions have restricted the sale of menthol cigarettes in addition to other flavored tobacco products.


In July, California Attorney General Rob Bonta joined a bipartisan coalition of state attorneys general calling on the US Food and Drug Administration (FDA) to adopt final regulatory standards to ban the production and sale of menthol cigarettes and flavored cigars in the US market. In a written statement, Bonta said, "Every day, millions of Californians smoke and begin down a dangerous path, leading to devastating health consequences." "There is no time to waste. We urge the FDA to swiftly finalize proposed regulations to ban menthol cigarettes and flavored cigars, which primarily harm young people and people of color. Any delay will only result in more lives lost.


Last year, the law exempting menthol cigarettes faced opposition from members of the Black Caucus, Mark Ridley-Thomas, Marqueece Harris Dawson, and Curren Price. They argued that studies have shown that African Americans are the most likely ethnic group to use menthol cigarettes, with a likelihood 25 times greater than that of white Americans.


Bonta has joined a coalition that includes attorneys general from Colorado, Connecticut, Delaware, Illinois, Pennsylvania, Idaho, Hawaii, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, North Carolina, Rhode Island, South Dakota, Vermont, Washington D.C. as well as Guam, Puerto Rico, and the U.S. Virgin Islands.


In a letter to the FDA, the Association of Attorneys General emphasized the need to remove these products from the market to protect public health and address the disproportionate and systemic impact on vulnerable minority communities.


The FDA should have taken action to ban menthol cigarettes and flavored cigars long ago, with sufficient scientific backing. They reference a study that found menthol cigarettes disproportionately harm vulnerable populations, particularly African Americans.


Overwhelming scientific evidence, including the FDA's own findings and statements, indicates that menthol cigarettes have a significant negative impact on public health, leading to increased smoking and tobacco use that result in more sickness and deaths.


A recent study published in the "Tobacco Control" journal found that mint-flavored cigarettes "caused over 10 million smokers and 378,000 premature deaths" between 1980 and 2018.


Mint flavoring masks the harsh taste of tobacco, which remains the primary reason young people start and become addicted to smoking - over half of adult smokers aged 18-34 use mint-flavored cigarettes.


In the LGBTQ+ community, among smokers with mental health issues, and in socioeconomically disadvantaged groups, the usage of menthol cigarettes is also high.


In August 2020, Governor Gavin Newsom signed Senate Bill 793, a bipartisan effort aimed at eliminating flavored electronic cigarettes, including candy and mint flavors, which he said "would addict our children." Last year, Newsom called on the FDA to ban mint-flavored cigarettes, saying it was "an important step in the right direction." In April 2021, Newsom urged the federal government to follow California's lead in protecting public health and promoting racial equality by banning menthol-flavored cigarettes. "For decades, Big Tobacco has targeted Black communities and profited from them by selling menthol cigarettes, making smoking-related illnesses the leading cause of death for African Americans in this country," he said.


The alliance stated in its letter that the proposed ban on menthol by the FDA is a crucial step in promoting health equity and protecting public health, and it will not significantly increase illegal trade.


Removing menthol cigarettes from the US market and banning flavors in cigars could potentially decrease smoking among young people, lead to better smoking cessation outcomes among adults, promote health equity, and benefit public health. This is according to a signed letter from 23 attorneys general representing various states and territories, who argue that inaction in these areas each year results in the loss of thousands of lives and has an adverse impact on the overall health of the public.


On the ballot for the November 8th election, Proposition 31 is a referendum on SB 793, aimed at lifting the current ban on the sale of flavored e-cigarettes, including mint and menthol, and flavored tobacco products in stores. A majority vote in favor will maintain the ban on flavored tobacco products, while a majority vote against will lift the ban.


Declaration


This article is compiled from third-party information and is intended only for industry exchange and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The compilation of this article is solely for internal industry research and communication purposes.


Due to limitations in translation ability, the translated article may not fully express the original text. Please refer to the original text for accuracy.


2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Japan Tobacco International (JTI) has introduced PERLZ nicotine pearls in the UK, expanding its oral nicotine portfolio beyond conventional nicotine pouches. The fully dissolvable, multi-layer pearls are placed under the tongue and come in Mint and Berry flavors at concentrations of 1mg/g and 2mg/g, equivalent to approximately 0.3mg and 0.5mg of nicotine per pearl. UK retailer Haypp published four 30-pearl dispenser listings on July 31, 2026, followed by three 10-pearl sachet products on August 17. The dispensers retail for £6.50, while the sachets cost £2.50.
product
Oct.12
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
U.S. Expands Illicit Vape Enforcement as ATF Brings PACT Act Powers Into Trade Fraud Task Force
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives said on September 23 that it has joined the interagency Trade Fraud Task Force to strengthen enforcement against illegal, misdeclared and smuggled vape and tobacco products. ATF will bring its authority under the Prevent All Cigarette Trafficking Act into the task force, including registration, reporting, shipping and record-inspection requirements covering interstate sales of electronic nicotine delivery systems. ATF said the move will strengthen its ability to trace illicit products from U.S. points of entry through domestic trafficking and distribution networks.
News
Sep.28 by 2Firsts Perspectives
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives